We are a stealth mode biotech startup.

Verdant Scientific is developing a first-in-class small molecule for the treatment of atopic dermatitis, more commonly known as eczema.

We are different.

Our molecule is different, our approach is different, and our results are different. Verdant Scientific’s lead drug candidate, VDT-002, will usher in a paradigm shift in how atopic dermatitis is treated.